Bio-Works Technologies AB has received a new order from a returning customer with an order value of 11 MSEK. The order relates to the delivery of the company's chromatography products and further strengthens the ongoing collaboration between the parties.
The customer operates within the biopharmaceutical industry and has previously used Bio-Works' products in its process development and production activities.
"We are pleased with the continued trust from our customer. Repeat orders confirm that our products deliver value and quality in our customers' processes," says Lone Carlbom, CEO of Bio-Works.
The order will be delivered as planned during Q2.
This disclosure contains information that Bio-Works Technologies AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014) and the Swedish Securities Markets Act (2007:528). The information was submitted for publication, through the agency of the contact person, on "Innehållet inom klamrarna kommer ersättas med rätt tid och datum vid utskickstillfället">17-02-2026 14:29 CET.